VIRAX BIOLABS GROUP LTD (VRAX) Stock Income Statement
NASDAQ:VRAX - Nasdaq - KYG9495L1251 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 84.90K | 156.40K | 8.60K | 0.00 | 120.00K | |||
| Minority Interest Expense | 1.10K | 5.60K | 300.00 | 40.00K | 20.00K | |||
| Cost Of Goods | 51.20K | 105.80K | 9.90K | 0.00 | 130.00K | |||
| Gross Profit | 33.60K | 50.60K | -1.40K | 0.00 | -10.00K | |||
| Operating Expenses | 6.31M | 6.16M | 5.73M | 1.73M | 640.00K | |||
| Research and Development | 1.88M | 1.56M | 397.10K | 430.00K | 120.00K | |||
| Selling, General, and Administrative Expenses | 4.43M | 4.59M | 5.33M | 1.30M | 510.00K | |||
| Operating Income | -6.28M | -6.11M | -5.73M | -1.73M | -640.00K | |||
| Interest Income/Expense | -42.40K | -26.90K | -15.50K | -20.00K | -30.00K | |||
| Other Income/Expense | 5.90K | -215.80K | 290.50K | 0.00 | 0.00 | |||
| Non Recurring Items | -402.80K | -390.40K | N/A | N/A | N/A | |||
| Income Before Taxes | -6.72M | -6.74M | -5.46M | -1.75M | -670.00K | |||
| Net Income | -6.58M | -6.73M | -5.46M | -1.71M | -650.00K | |||
| EBITDA | -6.04M | -6.00M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.60 | -3.36 | -5.13 | -0.15 | -0.06 | |||
| Statistics | ||||||||
| Gross Profit Margin | 39.58% | 32.35% | -16.28% | N/A | -8.33% | |||
| Profit Margin | -7750.65% | -4305.31% | -63459.30% | N/A | -541.67% | |||
| Operating Profit Margin | -7395.52% | -3904.16% | -66660.47% | N/A | -533.33% | |||
All data in USD